VOYA Investment Management Portfolio holdings
AUM
$100B
This Quarter Return
+10.47%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$96.6B
AUM Growth
+$96.6B
(+3.3%)
Cap. Flow
-$4.64B
Cap. Flow
% of AUM
-4.8%
Top 10 Holdings %
Top 10 Hldgs %
20.99%
Holding
3,099
New
205
Increased
1,608
Reduced
953
Closed
161
Top Buys
| 1 |
Adobe
ADBE
|
$623M |
| 2 |
Netflix
NFLX
|
$375M |
| 3 |
RTX Corp
RTX
|
$289M |
| 4 |
Caterpillar
CAT
|
$278M |
| 5 |
Danaher
DHR
|
$271M |
Top Sells
| 1 |
Microsoft
MSFT
|
$1.51B |
| 2 |
NVIDIA
NVDA
|
$898M |
| 3 |
Apple
AAPL
|
$699M |
| 4 |
DHR.PRB
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
|
$439M |
| 5 |
Booking.com
BKNG
|
$415M |
Sector Composition
| 1 | Technology | 30.93% |
| 2 | Healthcare | 11.24% |
| 3 | Consumer Discretionary | 9.94% |
| 4 | Financials | 7.18% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
eGain
EGAN
$172M
| $80.4K | ﹤0.01% | 10,730 +604 | +6% | +$4.52K |
|
2702
Ranpak Holdings
PACK
$445M
| $80.2K | ﹤0.01% | 17,752 +2,568 | +17% | +$11.6K |
|
2703
Lineage Cell Therapeutics
LCTX
$267M
| $79.8K | ﹤0.01% | +56,595 | New | +$79.8K |
|
2704
Vivid Seats
SEAT
$115M
| $79.8K | ﹤0.01% | +10,070 | New | +$79.8K |
|
2705
Tilly's
TLYS
$59.4M
| $79K | ﹤0.01% | +11,271 | New | +$79K |
|
|
USX
2706
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $78.8K | ﹤0.01% | +12,836 | New | +$78.8K |
|
2707
BRC Inc
BRCC
$176M
| $78.5K | ﹤0.01% | +15,205 | New | +$78.5K |
|
2708
Kaltura
KLTR
$246M
| $77.3K | ﹤0.01% | +36,476 | New | +$77.3K |
|
|
ITI
2709
DELISTED
Iteris, Inc.
ITI
| $77.3K | ﹤0.01% | +19,515 | New | +$77.3K |
|
|
TAST
2710
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $76.7K | ﹤0.01% | +15,217 | New | +$76.7K |
|
|
PHLT
2711
Performant Healthcare, Inc. Common Stock
PHLT
$603M
| $76.5K | ﹤0.01% | +28,350 | New | +$76.5K |
|
2712
Codexis
CDXS
$246M
| $76.5K | ﹤0.01% | 27,319 +3,194 | +13% | +$8.94K |
|
|
INZY
2713
DELISTED
Inozyme Pharma
INZY
| $76.2K | ﹤0.01% | +13,685 | New | +$76.2K |
|
2714
Zevra Therapeutics
ZVRA
$509M
| $75.8K | ﹤0.01% | +14,863 | New | +$75.8K |
|
2715
Sangamo Therapeutics
SGMO
$157M
| $75.6K | ﹤0.01% | 58,170 +8,652 | +17% | +$11.2K |
|
2716
Vera Bradley
VRA
$57.8M
| $75.4K | ﹤0.01% | +11,793 | New | +$75.4K |
|
|
VLD
2717
DELISTED
Velo3D, Inc.
VLD
| $75.3K | ﹤0.01% | 34,873 +13,847 | +66% | +$29.9K |
|
|
NSTG
2718
DELISTED
NanoString Technologies, Inc.
NSTG
| $75.1K | ﹤0.01% | 18,555 +525 | +3% | +$2.13K |
|
2719
Granite Ridge Resources
GRNT
$730M
| $75K | ﹤0.01% | +11,318 | New | +$75K |
|
2720
Quantum-Si Incorporated
QSI
$227M
| $74.7K | ﹤0.01% | 41,741 +7,026 | +20% | +$12.6K |
|
2721
Douglas Elliman
DOUG
$241M
| $73.5K | ﹤0.01% | 33,097 +3,266 | +11% | +$7.25K |
|
2722
CorMedix
CRMD
$1.11B
| $72.7K | ﹤0.01% | +18,325 | New | +$72.7K |
|
2723
Kezar Life Sciences
KZR
$28.9M
| $72K | ﹤0.01% | 29,376 +9,523 | +48% | +$23.3K |
|
2724
Humacyte
HUMA
$245M
| $71.2K | ﹤0.01% | 24,900 +3,726 | +18% | +$10.7K |
|
2725
Purple Innovation
PRPL
$126M
| $71.2K | ﹤0.01% | 25,597 +4,824 | +23% | +$13.4K |
|